Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation A Report of Two Cases

被引:14
作者
Anagnostis, Panagiotis [1 ]
Paschou, Stavroula A. [2 ]
Gonzalez-Rodriguez, Elena [3 ]
Potoupnis, Michael [4 ]
Tsiridis, Eleftherios [4 ]
Lamy, Olivier [3 ]
Goulis, Dimitrios G. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Med Sch, Dept Obstet & Gynecol 1, Unit Reprod Endocrinol, Thessaloniki, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Hosp, Div Endocrinol & Diabet, Athens, Greece
[3] Univ Lausanne Hosp SCHUV DAL, Ctr Bone Dis, Lausanne, Switzerland
[4] Aristotle Univ Thessaloniki, Med Sch, Papageorgiou Gen Hosp, C Acad Orthopaed Unit, Thessaloniki, Greece
关键词
POSTMENOPAUSAL WOMEN; BONE LOSS;
D O I
10.1097/RHU.0000000000000979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S581 / S584
页数:4
相关论文
共 16 条
  • [11] A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
    Langdahl, Bente L.
    Teglbjaerg, Christence Stubbe
    Ho, Pei-Ran
    Chapurlat, Roland
    Czerwinski, Edward
    Kendler, David L.
    Reginster, Jean-Yves
    Kivitz, Alan
    Lewiecki, E. Michael
    Miller, Paul D.
    Bolognese, Michael A.
    McClung, Michael R.
    Bone, Henry G.
    Ljunggren, Osten
    Abrahamsen, Bo
    Gruntmanis, Ugis
    Yang, Yu-Ching
    Wagman, Rachel B.
    Mirza, Faisal
    Siddhanti, Suresh
    Orwoll, Eric
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04) : 1335 - 1342
  • [12] Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up)
    Leder, Benjamin Z.
    Tsai, Joy N.
    Jiang, Linda A.
    Lee, Hang
    [J]. BONE, 2017, 98 : 54 - 58
  • [13] Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures
    Lehmann, T.
    Aeberli, D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (10) : 3067 - 3068
  • [14] Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis
    Popp, Albrecht Werner
    Varathan, Nadshathra
    Buffat, Helene
    Senn, Christoph
    Perrelet, Romain
    Lippuner, Kurt
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) : 50 - 54
  • [15] Bone Loss After Denosumab: Only Partial Protection with Zoledronate
    Reid, Ian R.
    Horne, Anne M.
    Mihov, Borislav
    Gamble, Gregory D.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2017, 101 (04) : 371 - 374
  • [16] Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates
    Tripto-Shkolnik, Liana
    Rouach, Vanessa
    Marcus, Yonit
    Rotman-Pikielny, Pnina
    Benbassat, Carlos
    Vered, Iris
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) : 44 - 49